WBP2 and breast cancer: The results support the notion that MST is a rheostat that controls the basal level of WBP2 in a diverse molecular subtypes of breast cancer including the TNBC (MDA-MB-468, MDA-MB-436, MDA-MB-231, BT549, and MDA-MB-453).